CNBC: "The Google for Investing Fintech"
Invest in the future with the future of investing. Search, discover, and invest in minutes – with Magnifi. No trade commissions.

No hidden execution charges.

Start investing today.
Learn more.
pixel

BGT Insider Trading (Bio-Gene Technology)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$10,181.89
Insider Selling (Last 12 Months): A$0.00

Bio-Gene Technology Insider Trading History Chart

This chart shows the insider buying and selling history at Bio-Gene Technology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bio-Gene Technology Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for BGT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
CNBC: "The Google for Investing Fintech"
Invest in the future with the future of investing. Search, discover, and invest in minutes – with Magnifi. No trade commissions.

No hidden execution charges.

Start investing today.
Learn more.
pixel

Bio-Gene Technology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/26/2021Robert KlupacsInsiderBuy72,212A$0.14A$10,181.89
9/16/2020Peter MayInsiderSell45,242A$0.17A$7,464.93
7/30/2020Peter MayInsiderIssued528,235A$0.07A$35,919.98
6/22/2020Peter MayInsiderBuy16,129A$0.16A$2,500.00
3/1/2019Donald BrumleyInsiderBuy150,000A$0.10A$15,000.00
See Full Table
Insider Buying at Bio-Gene Technology?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Bio-Gene Technology and related companies.

SEC Filings (Institutional Ownership Changes) for Bio-Gene Technology (ASX:BGT)

Bio-Gene Technology Limited, a biotechnology company, engages in developing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. It is involved in developing Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from the leaves of rare eucalyptus trees. The company has a research collaboration agreement with James Cook University for the development of a tissue culture system to support the expansion of tree plantations and scale-up of future Qcide oil production. It also has collaborations with Pacific Discovery Services for studying Flavocide's mode of action; and the Queensland Department of Agriculture and Fisheries for assessing activity against grain storage pests. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia.
Read More on Bio-Gene Technology

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Bio-Gene Technology?

Bio-Gene Technology's top insider investors include:
  1. Peter May (Insider)
  2. Robert Klupacs (Insider)
CNBC: "The Google for Investing Fintech"
Invest in the future with the future of investing. Search, discover, and invest in minutes – with Magnifi. No trade commissions.

No hidden execution charges.

Start investing today.
Learn more.
pixel